QA: Pharma-Bio Serv Inc. in us_consulting/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001304161_2023_Pharma_Bio_Serv_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001304161, Pharma-Bio Serv Inc.

  xvar xval
0 AssetsCurrent 19,943,603
1 IntangibleAssets 0
2 OperatingLeaseAssets 502,685
3 AssetsNoncurrent 204,558
4 remainder_Assets 0
5 LiabilitiesCurrent 2,107,719
6 LiabilitiesNoncurrent 346,509
7 remainder_Liabilities 1,639,048
8 CostOfRevenue 14,517,279
9 GeneralAndAdministrativeExpense 3,706,503
10 LaborExpense 0
11 remainder_Expenses 181,679
12 RevenueFromContractWithCustomer 0
13 RevenueFromReimbursement 0
14 remainder_Revenues 19,398,727
15 remainder_NetIncome 13,418
16 remainder_ComprehensiveNetIncome 93,697
  yvar yval
0 Assets 20,650,846
1 Liabilities 4,093,276
2 Expenses 18,405,461
3 Revenues 19,398,727
4 StockholdersEquity 16,557,570
5 NetIncome 1,006,684
6 ComprehensiveNetIncome 1,100,381
7 BaseVar 31,327,712
8 EconomicCapitalRatio 1.52

Edgar->Model Mapping

Feature Distribution

Change over Time